SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-283693
Filing Date
2023-11-28
Accepted
2023-11-28 07:33:03
Documents
18
Period of Report
2023-11-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d610145d8k.htm   iXBRL 8-K 44422
2 EX-3.1 d610145dex31.htm EX-3.1 30401
3 EX-10.1 d610145dex101.htm EX-10.1 65355
4 EX-99.1 d610145dex991.htm EX-99.1 23528
8 GRAPHIC g610145dsp14a.jpg GRAPHIC 3807
9 GRAPHIC g610145dsp14b.jpg GRAPHIC 6033
10 GRAPHIC g610145g1128084939980.jpg GRAPHIC 3643
  Complete submission text file 0001193125-23-283693.txt   358391

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA syre-20231122.xsd EX-101.SCH 2878
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE syre-20231122_lab.xml EX-101.LAB 20414
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syre-20231122_pre.xml EX-101.PRE 12681
12 EXTRACTED XBRL INSTANCE DOCUMENT d610145d8k_htm.xml XML 3986
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 231441897
SIC: 2834 Pharmaceutical Preparations